Industry news

• The head of the Rosselkhoznadzor: Russia produces analogues of almost all foreign vaccines against animal diseases

  24 June 2022 GxPnews

  Sergey Dankvert, the head of the Rosselkhoznadzor (the Federal Service for Veterinary and Phytosanitary Surveillance), said Russia produces analogues of almost all foreign vaccines against animal diseases. At the same time, there is no task to completely replace imports in this segment.

• New microencapsulation approach allows slow release of peptide drugs

  24 June 2022 Sarah Wills / European Pharmaceutical Review

  A new study from the University of Michigan shows a new method of drug microencapsulation, allowing several peptide drugs to be slowly released in the body.

• Machine learning model enables adventitious agent detection in cell cultures

  24 June 2022 Hannah Balfour / European Pharmaceutical Review

  Researchers have developed a rapid, label-free process analytical technology, called the anomaly detection model, to monitor microbial contamination in cell cultures in near-real-time.

• Patient empowerment goes from 'trend to permanent movement' as cancer trial interest grows

  23 June 2022 Gareth Macdonald / FierceBiotech

  Cancer patients from diverse backgrounds are finding empowerment in taking charge of their care as interest in clinical trial participation grows, according to TrialJectory.

• Technopolis Moscow will start producing therapies in the fall

  23 June 2022 GxPnews

  This fall, technopolis Moscow will start producing cell therapies. They will be supplied to clinics, burn emergency care centers and centers for disaster medicine. This is reported on the official website of the mayor of Moscow.

• SEZ Saint Petersburg to develop technologies for pharmaceutical industry

  22 June 2022 GxPnews

  Gazprom Neft and St. Petersburg will cooperate in the Special Economic Zone (SEZ) to develop technologies for the pharmaceutical industry. The parties will develop innovative technologies for obtaining chemical raw materials for drug components production. This is reported in the official Telegram channel of the SEZ Saint Petersburg.

• Ministry of Health: the pharmaceutical market has about 2 trillion rubles capitalization

  22 June 2022 GxPnews

  According to Sergey Glagolev,  Deputy Head of the Ministry of Health of the Russian Federation, the pharmaceutical market in Russia is growing steadily, with two–thirds of medicines being domestic drugs. He stated this during the International Research to Practice Conference “Assessment of healthcare technologies: improving the strategy for the development of the drug supply system”.

• In Russia, there are no plans to change the time intervals for revaccination against COVID-19

  21 June 2022 GxPnews

  Anna Popova, the head of Rospotrebnadzor, speaking in the margins of the St. Petersburg International Economic Forum (SPIEF), said that Russia has no plans to change the time intervals in the recommendations for COVID-19 revaccination.

• Murashko describes some measures aimed at counteracting possible new pandemics

  21 June 2022 GxPnews

  International cooperation between Russia and other countries in the production of vaccines continues. During the pandemic, several cardinal changes took place: a law on biological safety appeared, and several countries adopted the same legal regulation at the same time,  Mikhail Murashko, the Minister of Health of the Russian Federation, said during the session “Vaccine Production: International Cooperation in the Name of Health” at the 25th St. Petersburg International Economic Forum.

• The top 10 most profitable pharma companies in 2021

  20 June 2022 Angus Liu, Eric Sagonowsky, Kevin Dunleavy, Fraiser Kansteiner, Zoey Becker / FiercePharma

  While revenue reflects how well a pharma company’s products and services are selling, profit is an important metric that gives investors a look at the health of the business and how efficiently it has been managed.